Skip to content

Intra-abdominal Pressure in Peritoneal Dialysis Patients

Development of a Simplified Method to Measure Intra-abdominal Pressure in Peritoneal Dialysis Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02811640
Enrollment
12
Registered
2016-06-23
Start date
2016-06-30
Completion date
2019-04-25
Last updated
2020-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peritoneal Dialysis

Keywords

Intra-Abdominal Pressure, Stryker Pressure Monitor

Brief summary

Patients treated with peritoneal dialysis (PD) are at increased risk of developing mechanical complications such as dialysate leaks and hernias thought to be related to an increase in intra-abdominal pressure (IAP) secondary to the addition of dialysate to the abdomen. Resistance training has been shown to increase IAP but it is unclear in the general population and in patients treated with PD if this training increases the risk of developing hernias. This study is observing the difference in IAP pressure measurements obtained by the Stryker intracompartmental (STIC) pressure monitor versus the standard IAP pressure measurements obtained with the insufflator at the time of PD catheter insertion.

Detailed description

Ten patients who are having a peritoneal dialysis (PD) catheter inserted at the Ottawa Hospital, and who provide informed consent, will undergo intra-abdominal pressure (IAP) measurements with the Stryker intracompartmental (STIC) pressure monitor. Values will be compared to the insufflator at inflation pressures 5,10, and 15 mmHg (millimeters of mercury). To determine if the Stryker pressure monitor is appropriate for measuring IAP in PD patients, the observed pressures will be analyzed with Bland Altman plots. If the mean difference between readings is 5 mmHg and 95% of the points fall within 2 standard deviations of the mean difference, the Stryker pressure monitor will be considered an acceptable method of measuring IAP. This tool will then be used as part of a future larger trial which will 1) measure IAP with resistance training in patients treated with PD; with and without dialysate, 2) assess PD patient interest in participating in resistance training trials and 3) determine the appropriateness of the proposed resistance training program for this patient population. The ultimate goal is to use this study to help inform and develop a clinical trial to 1) assess the impact of resistance training on quality of life and functional status, 2) assess the risk of developing leaks/hernias, and 3) determine if there is an association between IAP during resistance training and subsequent hernia development

Interventions

IAP will be observed and measured with a hand held Stryker Pressure Monitor during laparoscopic surgery and compared to the standard IAP measurements obtained with the insufflator at the time of PD catheter insertion

Sponsors

Ottawa Hospital Research Institute
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients (\>18 years old) * Chronic kidney disease * Will have a PD catheter inserted in the operating room at the Ottawa Hospital using laparoscopic surgery

Exclusion criteria

* Patients who will have a non-standard PD catheter insertion position (eg parasternal)

Design outcomes

Primary

MeasureTime frameDescription
Intra-Abdominal Pressure (IAP)During laparoscopic surgery, up to 30 minutesThe Intra-Abdominal Pressure (IAP) measured with the Stryker monitor connected to the peritoneal dialysis (PD) catheter was compared with the insufflator pressures at of 15, 10, and 5 mm Hg.

Countries

Canada

Participant flow

Pre-assignment details

Two patients had to be excluded from the analysis due to difficulties zeroing the Stryker pressure monitor at the time of surgery.

Participants by arm

ArmCount
Study Participants
Adults with chronic kidney disease who will have a PD catheter inserted at the Ottawa Hospital Study Participants: IAP will be observed and measured with a hand held Stryker Pressure Monitor during laparoscopic surgery and compared to the standard IAP measurements obtained with the insufflator at the time of PD catheter insertion
12
Total12

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyTechnology malfunction2

Baseline characteristics

CharacteristicStudy Participants
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
4 Participants
Age, Categorical
Between 18 and 65 years
8 Participants
Age, Continuous53 years
STANDARD_DEVIATION 15
Race and Ethnicity Not Collected— Participants
Region of Enrollment
Canada
12 participants
Sex: Female, Male
Female
3 Participants
Sex: Female, Male
Male
9 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 12
other
Total, other adverse events
0 / 12
serious
Total, serious adverse events
0 / 12

Outcome results

Primary

Intra-Abdominal Pressure (IAP)

The Intra-Abdominal Pressure (IAP) measured with the Stryker monitor connected to the peritoneal dialysis (PD) catheter was compared with the insufflator pressures at of 15, 10, and 5 mm Hg.

Time frame: During laparoscopic surgery, up to 30 minutes

Population: There is only 1 arm or group for this study. The study participants are adults with chronic kidney disease who had a PD catheter inserted at the Ottawa Hospital. During the insertion, IAP was observed and measured with a hand held Stryker Pressure Monitor and with the insufflator. These results were compared, and the average difference and the standard deviation between the two are reported.

ArmMeasureGroupValue (MEAN)Dispersion
Study ParticipantsIntra-Abdominal Pressure (IAP)15 mm Hg-0.5 mm HgStandard Deviation 2
Study ParticipantsIntra-Abdominal Pressure (IAP)10 mm Hg-0.2 mm HgStandard Deviation 3.1
Study ParticipantsIntra-Abdominal Pressure (IAP)5 mm Hg-1.2 mm HgStandard Deviation 2.6

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026